Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease-Reference-Cited by-同舟云学术

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease

Published:2015-03 Issue:7544 Volume:519 Page:472-476
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Lee Dong I.,Zhu Guangshuo,Sasaki Takashi,Cho Gun-Sik,Hamdani Nazha,Holewinski Ronald,Jo Su-Hyun,Danner Thomas,Zhang Manling,Rainer Peter P.,Bedja Djahida,Kirk Jonathan A.,Ranek Mark J.,Dostmann Wolfgang R.,Kwon Chulan,Margulies Kenneth B.,Van Eyk Jennifer E.,Paulus Walter J.,Takimoto Eiki,Kass David A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature14332.pdf

Reference30 articles.

1. Takimoto, E. et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nature Med. 11, 214–222 (2005)

2. Kukreja, R. C., Salloum, F. N. & Das, A. Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. J. Am. Coll. Cardiol. 59, 1921–1927 (2012)

3. Mullershausen, F., Russwurm, M., Koesling, D. & Friebe, A. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation. Mol. Biol. Cell 15, 4023–4030 (2004)

4. Castro, L. R., Verde, I., Cooper, D. M. & Fischmeister, R. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes. Circulation 113, 2221–2228 (2006)

5. Takimoto, E. et al. Compartmentalization of cardiac β-adrenergic inotropy modulation by phosphodiesterase type 5. Circulation 115, 2159–2167 (2007)

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic Activation of N‐Nitrosamides with Red Light‐Triggered Nitric Oxide Release via Mediated Electron Transfer;Angewandte Chemie;2024-09-12

2. Biomimetic Activation of N‐Nitrosamides with Red Light‐Triggered Nitric Oxide Release via Mediated Electron Transfer;Angewandte Chemie International Edition;2024-09-12

3. Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced aberrant calcium transient;2024-09-04

4. Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced aberrant calcium transient;2024-09-04

5. The Role of Titin Phosphorylation in Changes in Myocardial Stiffness in Cardiomyopathies;Российский физиологический журнал им И М Сеченова;2024-09-01